| Age (years) |
|
|
|
|
| Mean (SD) |
70.5 (15.9) |
76.6 (16.2) |
70.9 (16) |
0.021 |
| Median (IQR) |
72 (20) |
80 (21) |
73 (21) |
|
| Gender |
148 (44%) |
14 (46.7%) |
162 (44.3%) |
0.782 |
| Female, n (%) |
|
|
|
|
| Systolic blood pressure (mm Hg), mean (SD) |
127.3 (27) |
116.0 (28.6) |
123.4 (27.5) |
0.035 |
| Heart rate (beats/min), mean (SD) |
89.5 (21.3) |
86.7 (26.7) |
89.3 (21.8) |
0.747 |
| Melena |
127 (37.8%) |
12 (40%) |
139 (38%) |
0.812 |
| Syncope in last 7 days |
19 (5.7%) |
5 (16.7%) |
24 (6.6%) |
0.037 |
| Altered mentation |
24 (7.1%) |
7 (23.3%) |
31 (8.5%) |
0.008 |
| Comorbidities |
|
|
|
|
| No major comorbidity |
65 (19.3%) |
2 (6.7%) |
67 (18.3%) |
< 0.0001 |
| Renal failure, liver failure, and/or disseminated malignancy |
120 (35.7%) |
22 (73.3%) |
142 (38.8%) |
|
| Any comorbidity except renal failure, liver failure, and/or disseminated malignancy |
151 (44.9%) |
6 (20.0%) |
157 (42.9%) |
|
| Congestive heart failure |
74 (22%) |
10 (33.3%) |
84 (23%) |
0.158 |
| Hepatic disease |
43 (12.8%) |
8 (26.7%) |
51 (13.9%) |
0.05 |
| Albumin < 3g/dL |
55 (16.4%) |
15 (50%) |
70 (19.1%) |
< 0.0001 |
| INR > 1.5 |
73 (21.7%) |
5 (16.7%) |
78 (21.3%) |
0.487 |
| Lactic acid , peak (mmol/L), mean (SD) |
2.2 (1.7) |
5.8 (5.5) |
2.4 (2.2) |
< 0.0001 |
| Hemoglobin(g/dL), mean (SD) |
10.4 (3) |
9.7 (2.7) |
10.3 (3) |
0.295 |
| BUN(mg/dL), mean (SD) |
33.3 (22) |
41.5 (27) |
33.8 (22.8) |
0.058 |
| Endoscopic diagnosis (n = 188) |
|
|
|
|
| No lesion or stigmata of recent bleed |
41 (23.6%) |
2 (14.3%) |
43 (22.9%) |
0.316 |
| Malignancy of upper GI tract |
3 (1.7%) |
1 (7.1%) |
4 (2.1%) |
|
| All other diagnosis |
130 (74.7%) |
11 (78.6%) |
141 (75%) |
|
| Hemorrhage stigmata (n = 189) |
67 (38.3%) |
11 (78.6%) |
78 (41.3%) |
0.003 |
